Lifevantage (NASDAQ:LFVN) is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.
Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market. The company’s research and development efforts focus on leveraging cellular biology insights to create products that support antioxidant activity and overall well-being. Its sales force operates on a multi-level marketing framework, earning commissions through personal and team retail sales.
LifeVantage maintains a global presence, with active markets in North America, Europe, Asia-Pacific and South Africa. Through this international footprint, the company serves health-conscious consumers across more than 30 markets. Distributors utilize online platforms and in-person presentations to educate customers about the science behind each product and to build a recurring revenue base.
Governed by a board of directors and a senior management team, LifeVantage places emphasis on product innovation, regulatory compliance and distributor training. The company continues to explore partnerships and clinical collaborations aimed at validating its formulations and expanding its reach within the competitive health and wellness industry.
